AI assistant
TG THERAPEUTICS, INC. — Director's Dealing 2024
Jan 9, 2024
31066_dirs_2024-01-08_26d39a48-faba-4b96-9272-79fc5e60e5ed.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TG THERAPEUTICS, INC. (TGTX)
CIK: 0001001316
Period of Report: 2024-01-05
Reporting Person: Charney Laurence N (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-05 | Common Stock | S | 17500 | $19.03 | Disposed | 237229 | Direct |
Footnotes
F1: In connection with the vesting of 58,732 shares on January 4, 2024, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Charney's income tax obligations. Mr. Charney had no discretion with respect to such sale, which was transacted in accordance with the Company's corporate policies regarding the vesting of restricted stock.
F2: Reflects the weighted average sale price. The range of prices for the shares sold was $19.01 to $19.06. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Includes shares of restricted Common Stock, which vest over various time periods.